Nuvve (Nasdaq: NVVE) to Report Annual Financial Results on Thursday, March 28, 2024

SAN DIEGO, March 21, 2024 /PRNewswire/ — Nuvve Holding Corp. (Nasdaq: NVVE), a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform, today announced that it will conduct a conference call to review the annual financial results at 5 PM ET (2 PM PT) on Thursday, March 28, 2024.  The Company will issue a press release detailing […]

Longeveron (NASDAQ: LGVN) Announces 1-for-10 Reverse Stock Split

MIAMI, March 19, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that the Company’s Board of Directors has approved a 1-for-10 reverse split of the Company’s Class A common stock, par value $0.001 per share and Class B […]

OKYO Pharma (NASDAQ: OKYO) to Release New and Comprehensive Data from Phase 2 Dry Eye Disease Trial and Host Key Opinion Leader Event

LONDON and NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA […]

Splash Beverage (NYSE American: SBEV) Expands Distribution Network for Beverage Brands, Secures Retailer Partnerships

Vancouver, Canada –News Direct– Splash Beverage Group Inc Splash Beverage CEO Robert Nistico joined Steve Darling from Proactive to share exciting updates about the company’s expanding distribution network for its beverage brands. Splash Beverage owns a growing portfolio of alcoholic and non-alcoholic beverage brands, including Copa di Vino wines by the glass, SALT Naturally Flavored […]

SciSparc (Nasdaq: SPRC) Granted Another Patent, Strengthening its Core Technology in Canada

TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today announced that it has been granted a patent for its core-technology, the combination of cannabinoids and […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.